Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. administers nearly 349 million doses of COVID-19 vaccines - CDC

Published 08/05/2021, 02:19 PM
Updated 08/05/2021, 02:20 PM
© Reuters. FILE PHOTO: People wait in line to be inoculated against the coronavirus disease (COVID-19) at a vaccination site at the Esports Stadium Arlington & Expo Center in Arlington, Texas, U.S. February 12, 2021.  REUTERS/Cooper Neill

(Reuters) - The United States has administered 348,966,419 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 403,047,945 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 348,102,478 vaccine doses the CDC said had gone into arms by Aug. 4, out of 402,010,455 doses delivered.

The agency said 193,199,353 people had received at least one dose, while 165,637,566 people were fully vaccinated as of Thursday.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine as of 6:00 a.m. ET on Thursday.

Latest comments

Alpha Betha Gamma Delta Epsilon
How many vacsinated infected with Delta ?
“and the question is whether or not we should be in a position where are why can’t the experts say we know that this virus is in fact we know it’s going to be or excuse me, we know why the all the drugs approved are not temporarily approved and but permanently approved, that’s underway too.” - Joe Biden
Pray for the vaccinated daily.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.